US FDA Extends Review of Ascendis Pharma’s Therapy for Children With Dwarfism
Wedoany.com Report-Nov. 27, The U.S. Food and Drug Administration has extended its review of Ascendi...
US Medicare Price Cuts Manageable for Most Drugmakers, Analysts Say
Wedoany.com Report-Nov. 27, The European Commission has approved Dupixent (dupilumab), developed by ...
Dupixent Gains Chronic Spontaneous Urticaria Indication in Europe
Wedoany.com Report-Nov. 27, The European Commission has approved Dupixent (dupilumab), developed by ...
Novo Nordisk’s Amycretin Cuts Body Weight, Blood Sugar in Phase 2 Diabetes Trial
Wedoany.com Report-Nov. 26, Novo Nordisk has announced positive mid-stage clinical results for its e...
Novartis Wins Approval to Use SMA Gene Therapy in Older Patients
Wedoany.com Report-Nov. 26, The U.S. Food and Drug Administration has approved Novartis’ new gene th...
Eli Lilly Becomes First Drugmaker to Hit $1 Trillion in Market Value
Wedoany.com Report-Nov. 26, Eli Lilly briefly became the world’s first pharmaceutical company to rea...
US Slashes 36% off Medicare Spending on 15 High-Priced Medicines
Wedoany.com Report-Nov. 26, The U.S. Medicare program announced on Tuesday that newly negotiated pri...
Novo Nordisk Alzheimer’s Drug Trials Fail in Blow to Weight-Loss Giant
Wedoany.com Report-Nov. 25, Novo Nordisk (NOVOb.CO) announced on Monday that two large Phase III tri...
Bayer Shares up More Than 8% on Revived Fortunes for Blood Thinner
Wedoany.com Report-Nov. 25, Bayer (BAYGn.DE) shares rose more than 8 percent on Monday after the com...
Gavi, Unicef Sign Deal to Cut Malaria Vaccine Price
Wedoany.com Report-Nov. 25, Gavi, the global vaccine alliance, and Unicef have secured an agreement ...